We are analyzing https://link.springer.com/article/10.1007/s13277-014-2272-7.

Title:
Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A) | Tumor Biology
Description:
Recently, we reported that anticancer bioactive peptide (ACBP), purified from goat spleens immunized with human gastric cancer extracts, significantly inhibited gastric cancer cells in vitro and gastric tumors in vivo via repressing cell growth and promoting apoptosis, making it a promising potential biological anticancer drug. However, it is not known what genes are functionally required for the ACBP effects. Here, we first found that two tumor suppressor genes, cyclin-dependent kinase inhibitor 2B (CDKN2B) and growth arrest and DNA damage-inducible alpha (GADD45A), were upregulated significantly in the cells with ACBP treatment by microarray screening and the findings were validated by real-time RT-PCR. Next, GADD45A mRNA and protein expressions were downregulated in the gastric cancer cells by lentivirus-mediated RNAi; then, cell viability, cell cycle, and apoptosis were assayed by MTT and flow cytometry. Interestingly, our results indicated that cell viability was not dependent on GADD45A without ACBP treatment; however, cell sensitivity to ACBP was significantly decreased in ACBP-treated gastric cancer cells with GADD45A downregulation. Therefore, we demonstrate that GADD45A was functionally required for ACBP to inhibit gastric cancer cells, suggesting that GADD45A may become a biomarker for ACBP sensitivity. Our findings have significant implications on the molecular mechanism understanding, biomarker development, and anticancer drug development of ACBP.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cell, article, cancer, google, scholar, anticancer, bioactive, pubmed, gastric, peptide, cycle, acbp, gadda, cells, human, research, growth, xin, apoptosis, cas, chin, privacy, cookies, content, tumor, zhang, access, proteins, information, publish, search, liu, viability, yang, wang, gadd, analysis, data, log, journal, biology, inhibits, arrest, dna, damageinducible, liya, hongyi, hongwu, xiulan, goat,

Topics {✒️}

dna damage-inducible alpha anti-cancer bioactive peptide anti-cancer bioactive peptide anticancer bioactive peptide month download article/chapter tumor suppressor genes jnk-dependent signaling pathways xiu-lan su hong-wu xin real-time rt-pcr hong-yi xin gastric cancer cells maldi-tof-ms analysis anticancer drug development gastric cancer bgc-823 repressing cell growth research article published protein expressions tront js cell cycle regulation cell cycle machinery full article pdf related subjects upregulating growth arrest cell cycle control privacy choices/manage cookies oncogene yong-lei liu article su cell viability cell sensitivity cell cycle stress signaling check access instant access european economic area lentivirus-mediated rnai acta anat sin brown-clay jd fornace jr aj crit rev oncog biomedical sciences institutes tumor biol growth arrest conditions privacy policy article log author information authors molecular biology chin med biotechnol accepting optional cookies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A)
         description:Recently, we reported that anticancer bioactive peptide (ACBP), purified from goat spleens immunized with human gastric cancer extracts, significantly inhibited gastric cancer cells in vitro and gastric tumors in vivo via repressing cell growth and promoting apoptosis, making it a promising potential biological anticancer drug. However, it is not known what genes are functionally required for the ACBP effects. Here, we first found that two tumor suppressor genes, cyclin-dependent kinase inhibitor 2B (CDKN2B) and growth arrest and DNA damage-inducible alpha (GADD45A), were upregulated significantly in the cells with ACBP treatment by microarray screening and the findings were validated by real-time RT-PCR. Next, GADD45A mRNA and protein expressions were downregulated in the gastric cancer cells by lentivirus-mediated RNAi; then, cell viability, cell cycle, and apoptosis were assayed by MTT and flow cytometry. Interestingly, our results indicated that cell viability was not dependent on GADD45A without ACBP treatment; however, cell sensitivity to ACBP was significantly decreased in ACBP-treated gastric cancer cells with GADD45A downregulation. Therefore, we demonstrate that GADD45A was functionally required for ACBP to inhibit gastric cancer cells, suggesting that GADD45A may become a biomarker for ACBP sensitivity. Our findings have significant implications on the molecular mechanism understanding, biomarker development, and anticancer drug development of ACBP.
         datePublished:2014-07-12T00:00:00Z
         dateModified:2014-07-12T00:00:00Z
         pageStart:10051
         pageEnd:10056
         sameAs:https://doi.org/10.1007/s13277-014-2272-7
         keywords:
            Anticancer bioactive peptide
            Gastric cancer
            Cell viability
            Apoptosis
            Cell cycle
            CDKN2B
            GADD45A
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-014-2272-7/MediaObjects/13277_2014_2272_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-014-2272-7/MediaObjects/13277_2014_2272_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-014-2272-7/MediaObjects/13277_2014_2272_Fig3_HTML.gif
         isPartOf:
            name:Tumor Biology
            issn:
               1423-0380
               1010-4283
            volumeNumber:35
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Li-Ya Su
               affiliation:
                     name:Inner Mongolia Medical University
                     address:
                        name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hong-Yi Xin
               affiliation:
                     name:Agency for Science, Technology and Research (A*STAR)
                     address:
                        name:Biomolecular Function Discovery Division, Bioinformatics Institute, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yong-Lei Liu
               affiliation:
                     name:Fudan University
                     address:
                        name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jia-Ling Zhang
               affiliation:
                     name:Inner Mongolia Medical University
                     address:
                        name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hong-Wu Xin
               affiliation:
                     name:Inner Mongolia Medical University
                     address:
                        name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Xiu-Lan Su
               affiliation:
                     name:Inner Mongolia Medical University
                     address:
                        name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A)
      description:Recently, we reported that anticancer bioactive peptide (ACBP), purified from goat spleens immunized with human gastric cancer extracts, significantly inhibited gastric cancer cells in vitro and gastric tumors in vivo via repressing cell growth and promoting apoptosis, making it a promising potential biological anticancer drug. However, it is not known what genes are functionally required for the ACBP effects. Here, we first found that two tumor suppressor genes, cyclin-dependent kinase inhibitor 2B (CDKN2B) and growth arrest and DNA damage-inducible alpha (GADD45A), were upregulated significantly in the cells with ACBP treatment by microarray screening and the findings were validated by real-time RT-PCR. Next, GADD45A mRNA and protein expressions were downregulated in the gastric cancer cells by lentivirus-mediated RNAi; then, cell viability, cell cycle, and apoptosis were assayed by MTT and flow cytometry. Interestingly, our results indicated that cell viability was not dependent on GADD45A without ACBP treatment; however, cell sensitivity to ACBP was significantly decreased in ACBP-treated gastric cancer cells with GADD45A downregulation. Therefore, we demonstrate that GADD45A was functionally required for ACBP to inhibit gastric cancer cells, suggesting that GADD45A may become a biomarker for ACBP sensitivity. Our findings have significant implications on the molecular mechanism understanding, biomarker development, and anticancer drug development of ACBP.
      datePublished:2014-07-12T00:00:00Z
      dateModified:2014-07-12T00:00:00Z
      pageStart:10051
      pageEnd:10056
      sameAs:https://doi.org/10.1007/s13277-014-2272-7
      keywords:
         Anticancer bioactive peptide
         Gastric cancer
         Cell viability
         Apoptosis
         Cell cycle
         CDKN2B
         GADD45A
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-014-2272-7/MediaObjects/13277_2014_2272_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-014-2272-7/MediaObjects/13277_2014_2272_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-014-2272-7/MediaObjects/13277_2014_2272_Fig3_HTML.gif
      isPartOf:
         name:Tumor Biology
         issn:
            1423-0380
            1010-4283
         volumeNumber:35
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Li-Ya Su
            affiliation:
                  name:Inner Mongolia Medical University
                  address:
                     name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hong-Yi Xin
            affiliation:
                  name:Agency for Science, Technology and Research (A*STAR)
                  address:
                     name:Biomolecular Function Discovery Division, Bioinformatics Institute, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yong-Lei Liu
            affiliation:
                  name:Fudan University
                  address:
                     name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jia-Ling Zhang
            affiliation:
                  name:Inner Mongolia Medical University
                  address:
                     name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hong-Wu Xin
            affiliation:
                  name:Inner Mongolia Medical University
                  address:
                     name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Xiu-Lan Su
            affiliation:
                  name:Inner Mongolia Medical University
                  address:
                     name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Tumor Biology
      issn:
         1423-0380
         1010-4283
      volumeNumber:35
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Inner Mongolia Medical University
      address:
         name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
         type:PostalAddress
      name:Agency for Science, Technology and Research (A*STAR)
      address:
         name:Biomolecular Function Discovery Division, Bioinformatics Institute, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
         type:PostalAddress
      name:Fudan University
      address:
         name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
         type:PostalAddress
      name:Inner Mongolia Medical University
      address:
         name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
         type:PostalAddress
      name:Inner Mongolia Medical University
      address:
         name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
         type:PostalAddress
      name:Inner Mongolia Medical University
      address:
         name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Li-Ya Su
      affiliation:
            name:Inner Mongolia Medical University
            address:
               name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
               type:PostalAddress
            type:Organization
      name:Hong-Yi Xin
      affiliation:
            name:Agency for Science, Technology and Research (A*STAR)
            address:
               name:Biomolecular Function Discovery Division, Bioinformatics Institute, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
               type:PostalAddress
            type:Organization
      name:Yong-Lei Liu
      affiliation:
            name:Fudan University
            address:
               name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Jia-Ling Zhang
      affiliation:
            name:Inner Mongolia Medical University
            address:
               name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
               type:PostalAddress
            type:Organization
      name:Hong-Wu Xin
      affiliation:
            name:Inner Mongolia Medical University
            address:
               name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Xiu-Lan Su
      affiliation:
            name:Inner Mongolia Medical University
            address:
               name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
      name:Biomolecular Function Discovery Division, Bioinformatics Institute, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
      name:Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
      name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
      name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
      name:Clinical Medicine Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(70)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.13s.

LINK . SPRINGER . COM {}